DE69738312D1 - Hepatitis b monoklonale antikörper - Google Patents

Hepatitis b monoklonale antikörper

Info

Publication number: DE69738312D1
Authority: DE; Germany
Prior art keywords: hepatitis; monoclonal antibodies; monoclonal; antibodies
Prior art date: 1996-04-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69738312T

Other languages

English (en)

Other versions

DE69738312T2 (de

Inventor

Richard Seton Tedder

Samreen Ijaz

Ruth Bridget Ferns

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Murex Diagnostics Corp

Original Assignee

Murex Diagnostics Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-25

Filing date

1997-04-25

Publication date

2008-01-03

1997-04-25 Application filed by Murex Diagnostics Corp filed Critical Murex Diagnostics Corp

2008-01-03 Publication of DE69738312D1 publication Critical patent/DE69738312D1/de

2008-10-02 Application granted granted Critical

2008-10-02 Publication of DE69738312T2 publication Critical patent/DE69738312T2/de

2017-04-26 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Oncology (AREA)
Immunology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DE69738312T 1996-04-25 1997-04-25 Hepatitis b monoklonale antikörper Expired - Lifetime DE69738312T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9608626.9A GB9608626D0 (en)	1996-04-25	1996-04-25	Hepatitis b monoclonal antibodies
GB9608626		1996-04-25
PCT/GB1997/001161 WO1997040164A1 (en)	1996-04-25	1997-04-25	Hepatitis b monoclonal antibodies

Publications (2)

Publication Number	Publication Date
DE69738312D1 true DE69738312D1 (de)	2008-01-03
DE69738312T2 DE69738312T2 (de)	2008-10-02

Family

ID=10792667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69738312T Expired - Lifetime DE69738312T2 (de)	1996-04-25	1997-04-25	Hepatitis b monoklonale antikörper

Country Status (10)

Country	Link
US (1)	US7393933B1 (de)
EP (1)	EP0904378B1 (de)
JP (1)	JP4118955B2 (de)
AU (1)	AU2645297A (de)
CA (1)	CA2252466C (de)
DE (1)	DE69738312T2 (de)
ES (1)	ES2297855T3 (de)
GB (1)	GB9608626D0 (de)
WO (1)	WO1997040164A1 (de)
ZA (1)	ZA973664B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL118626A0 (en)	1996-06-11	1996-10-16	Xtl Biopharmaceuticals Limited	Anti HBV antibody
CA2274585A1 (en) *	1996-12-30	1998-07-09	Innogenetics N.V.	Annexin v-binding polypeptides derived from hbsag and their uses
EP1111388A1 (de) *	1999-12-23	2001-06-27	Universiteit Gent	Interaktion zwischen CD14 und HBV-Komponenten
EP1142906A1 (de) *	2000-03-31	2001-10-10	Ortho-Clinical Diagnostics, Inc.	Eine Variante des Hepatitis B Virus (ayw Subtyp) Oberflächenantigenes
FR2815634B1 (fr) *	2000-10-20	2003-10-31	Biomerieux Sa	Anticorps monoclonaux diriges contre des virus de l'hepatite b
DE10339927A1 (de) *	2003-08-29	2005-03-24	Rhein Biotech Gesellschaft für neue Biotechnologische Prozesse und Produkte mbH	Zusammensetzung zur Prophylaxe/Therapie von HBV-Infektionen und HBV-vermittelten Erkrankungen
ES2488849T3 (es) *	2004-06-07	2014-08-29	Novartis Vaccines And Diagnostics, Inc.	Anticuerpos monoclonales de conejo a antígenos de superficie de hepatitis B y métodos de utilización de los mismos
EP1848740A1 (de) *	2005-01-14	2007-10-31	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, the Department of Health and Human Services,	An hepatitis-b-virus bindende oder dieses neutralisierende monoklonale antikörper
JP4948783B2 (ja)	2005-05-18	2012-06-06	シスメックス株式会社	抗ＨＢｓモノクローナル抗体
WO2008053901A1 (en) *	2006-10-30	2008-05-08	Advanced Life Science Institute, Inc.	METHOD FOR ANALYSIS OF HEPATITIS B VIRUS s ANTIGEN
AU2016238246B2 (en)	2015-03-25	2021-05-13	Igm Biosciences, Inc.	Multi-valent hepatitis B virus antigen binding molecules and uses thereof
WO2017059878A1 (en) *	2015-10-07	2017-04-13	Humabs Biomed Sa	Antibodies that potently neutralize hepatitis b virus and uses thereof
KR102561555B1 (ko) *	2017-04-07	2023-07-31	시아먼 유니버시티	Ｂ형 간염 감염 및 관련 질병의 치료를 위한 항체
KR102084912B1 (ko) *	2019-01-17	2020-03-05	주식회사 녹십자	B형 간염 바이러스 표면 항원의 입체 에피토프 및 이에 특이적으로 결합하는 항체
CN111659355B (zh) *	2020-06-23	2022-12-13	武汉瑞法医疗器械有限公司	烷基化修饰的乙肝病毒免疫吸附剂及其制备方法
JP7629837B2 (ja)	2021-10-22	2025-02-14	株式会社アマダ	レーザ加工機

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU681636B2 (en) *	1993-03-24	1997-09-04	Imperial College Of Science, Technology And Medicine	Hepatitis B escape mutant specific binding molecules
GB9401987D0 (en) *	1994-02-02	1994-03-30	Imperial College	Modified nucleic acid

1996
- 1996-04-25 GB GBGB9608626.9A patent/GB9608626D0/en active Pending
1997
- 1997-04-25 AU AU26452/97A patent/AU2645297A/en not_active Abandoned
- 1997-04-25 EP EP97918255A patent/EP0904378B1/de not_active Expired - Lifetime
- 1997-04-25 ZA ZA973664A patent/ZA973664B/xx unknown
- 1997-04-25 ES ES97918255T patent/ES2297855T3/es not_active Expired - Lifetime
- 1997-04-25 US US09/402,282 patent/US7393933B1/en not_active Expired - Fee Related
- 1997-04-25 DE DE69738312T patent/DE69738312T2/de not_active Expired - Lifetime
- 1997-04-25 JP JP53786797A patent/JP4118955B2/ja not_active Expired - Lifetime
- 1997-04-25 CA CA2252466A patent/CA2252466C/en not_active Expired - Lifetime
- 1997-04-25 WO PCT/GB1997/001161 patent/WO1997040164A1/en active IP Right Grant

Also Published As

Publication number	Publication date
CA2252466C (en)	2010-04-06
JP4118955B2 (ja)	2008-07-16
ES2297855T3 (es)	2008-05-01
AU2645297A (en)	1997-11-12
JP2000509269A (ja)	2000-07-25
ZA973664B (en)	1998-08-20
US7393933B1 (en)	2008-07-01
CA2252466A1 (en)	1997-10-30
EP0904378B1 (de)	2007-11-21
WO1997040164A1 (en)	1997-10-30
EP0904378A1 (de)	1999-03-31
GB9608626D0 (en)	1996-07-03
DE69738312T2 (de)	2008-10-02

Publication	Publication Date	Title
DK1516629T3 (da)	2013-06-03	Humaniseret anti-CD-11a antibodies
NO955167D0 (no)	1995-12-19	Monoklonalt anti-
DE69920897D1 (de)	2004-11-11	Monoklonale antikörper mit verringerter immunisierungsfähigkeit
FI965032L (fi)	1996-12-16	Interleukiini-5-spesifisiä yhdistelmä-vasta-aineita
CY2005008I2 (el)	2017-11-14	Αντισωματα αντι - vegf
IL128406A0 (en)	2000-01-31	Monoclonal antibodies
NO985464D0 (no)	1998-11-23	Konsentrert antistoffpreparat
DK145493D0 (da)	1993-12-23	Antistof
DK0837927T3 (da)	2008-05-13	Anti-CD80-antistoffer
FI964845L (fi)	1996-12-04	CD44v6:n vastaiset monoklonaaliset vasta-aineet
DE69935516D1 (de)	2007-04-26	Antikörper mit verbesserter produzierbarkeit
DE69738312D1 (de)	2008-01-03	Hepatitis b monoklonale antikörper
FI945865L (fi)	1995-02-08	Glykoprofeiini P:lle kohdistettuja monoklonaalisia vasta-aineita
DE69828154D1 (de)	2005-01-20	Anti-alphavbeta3 humanizierte monoklonale antikörper
NO981454L (no)	1998-10-02	Anti-FAS-antistoffer
BR9509902A (pt)	1997-10-21	Fragmentos de anticorpos monoclonais apresentando atividade imunosupressante
NO20011006D0 (no)	2001-02-27	Høy-affinitets antistoffer
GB9718911D0 (en)	1997-11-12	Monoclonal antibodies
DE69427850D1 (de)	2001-09-06	Monoklonaler antikörper gegen mucoglykoprotein
NO985281D0 (no)	1998-11-12	Monoklonalt antihumant MP52-antistoff
GB9722944D0 (en)	1998-01-07	Hepatitis B virus monoclonal antibodies
GB9722943D0 (en)	1998-01-07	Hepatitis B virus monoclonal antibodies
DE69324928D1 (de)	1999-06-17	Monoklonaler antikörper
BR1100555B1 (pt)	2009-01-13	anticorpos monoclonais humanizados.
GB9615027D0 (en)	1996-09-04	Monoclonal antibodies

Legal Events

Date	Code	Title	Description
2008-12-11	8364	No opposition during term of opposition